Skip to main content
Have a personal or library account? Click to login
Moleculary Confirmed, Cytogenetic Remission in a Case with Myelodysplastic Syndrome Treated with Azacitidne Cover

Moleculary Confirmed, Cytogenetic Remission in a Case with Myelodysplastic Syndrome Treated with Azacitidne

PRILOZI
Volume 38 (2017): Issue 3 (December 2017)
By: Irina Panovska-Stavridis,  Martin Ivanovski,  Sanja Trajkova,  Aleksandra Pivkova-Veljanovska,  Marija Popova-Labaceska,  Nadica Matevska-Geshovska,  Predrag Noveski,  Dijana Plaseska-Karanfilska,  Lidija Cevreska and  Aleksandar J. Dimovski  
Open Access
|Apr 2018
Articles in this issue
DOI: https://doi.org/10.2478/prilozi-2018-0017 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 157 - 162
Published on: Apr 16, 2018
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Myelodysplastic syndrome (MDS),
Azacitidine,
Y chromosome
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2018 Irina Panovska-Stavridis, Martin Ivanovski, Sanja Trajkova, Aleksandra Pivkova-Veljanovska, Marija Popova-Labaceska, Nadica Matevska-Geshovska, Predrag Noveski, Dijana Plaseska-Karanfilska, Lidija Cevreska, Aleksandar J. Dimovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 38 (2017): Issue 3 (December 2017)
Previous article
Next article